MA42910A - Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène - Google Patents

Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène

Info

Publication number
MA42910A
MA42910A MA42910A MA42910A MA42910A MA 42910 A MA42910 A MA 42910A MA 42910 A MA42910 A MA 42910A MA 42910 A MA42910 A MA 42910A MA 42910 A MA42910 A MA 42910A
Authority
MA
Morocco
Prior art keywords
hydrogen peroxide
compositions
phase
antimicrobial compositions
peroxide releasing
Prior art date
Application number
MA42910A
Other languages
English (en)
Inventor
John Reginald Barrett
James Brennan
Sophie Constance Cox
Liam Michael Grover
Thomas Jon Hall
Thomas Patton
Rami Salib
Ian Staples
Original Assignee
Matoke Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1513045.3A external-priority patent/GB201513045D0/en
Application filed by Matoke Holdings Ltd filed Critical Matoke Holdings Ltd
Publication of MA42910A publication Critical patent/MA42910A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Animal Husbandry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Des compositions pour générer une activité antimicrobienne sont décrites. Les compositions comprennent: une première phase; une deuxième phase; une enzyme capable de convertir un substrat pour libérer du peroxyde d'hydrogène; et une substance qui comprend un substrat pour l'enzyme, la première phase et la seconde phase étant non miscibles. Les compositions peuvent être formulées sous forme de colloïdes, de suspensions ou d'émulsions, en particulier sous forme de crèmes ou de sprays. Des procédés de fabrication des compositions sont décrits, ainsi que leur utilisation pour le traitement d'infections antimicrobiennes.
MA42910A 2015-07-23 2016-07-22 Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène MA42910A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1513045.3A GB201513045D0 (en) 2015-07-23 2015-07-23 Antimicrobial compositions and formulations
GB201606249 2016-04-12

Publications (1)

Publication Number Publication Date
MA42910A true MA42910A (fr) 2018-05-30

Family

ID=56555490

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42910A MA42910A (fr) 2015-07-23 2016-07-22 Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène

Country Status (16)

Country Link
US (1) US20180318399A1 (fr)
EP (1) EP3324998A1 (fr)
JP (1) JP2018527320A (fr)
KR (1) KR20180051501A (fr)
CN (1) CN107847566A (fr)
AU (1) AU2016296150A1 (fr)
BR (1) BR112018001279A2 (fr)
CA (1) CA2990326A1 (fr)
CO (1) CO2018001628A2 (fr)
GB (1) GB2556567A (fr)
HK (1) HK1256251A1 (fr)
MA (1) MA42910A (fr)
MX (1) MX2018001002A (fr)
PH (1) PH12018500374A1 (fr)
RU (1) RU2018105622A (fr)
WO (1) WO2017013448A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ726323A (en) 2014-04-30 2020-02-28 Matoke Holdings Ltd Antimicrobial compositions
WO2018065789A1 (fr) * 2016-10-06 2018-04-12 Matoke Holdings Limited Compositions antimicrobiennes
US20200069777A1 (en) * 2016-11-15 2020-03-05 Matoke Holdings Limited Antimicrobial compositions and formulations
WO2019077336A1 (fr) * 2017-10-16 2019-04-25 Matoke Holdings Limited Double distributeur contenant de l'eau et une composition antimicrobienne
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
CN107668320A (zh) * 2017-11-03 2018-02-09 杭州市农业科学研究院 以蜂蜜为原料的饲料添加剂及其制备方法
WO2020022989A2 (fr) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Compositions topiques pour soins de peau de bébé
CN110734563B (zh) * 2018-07-20 2022-05-17 南京理工大学 细菌纤维素/鸸鹋油复合膜及其制备方法
US20220175829A1 (en) 2019-03-27 2022-06-09 Matoke Holdings Limited Antimicrobial Compositions
CN111631271A (zh) * 2020-05-22 2020-09-08 南昌大学 一种稳定w/o/w型多重乳液的制备方法
PL245030B1 (pl) * 2020-06-01 2024-04-22 Healthcann Spolka Z Ograniczona Odpowiedzialnoscia Samoemulgująca się kompozycja zawierająca kannabinoidy, jej zastosowanie, stabilny układ monodyspersyjny oraz sposób jego wytwarzania
EP4255516B1 (fr) * 2020-12-01 2025-08-13 Rossana Castellana Formulations pour la cicatrisation de lésions traumatiques de la peau et de muqueuses
WO2023227599A1 (fr) * 2022-05-23 2023-11-30 Atlantic Technological University Composition de revêtement antimicrobienne
GB202309435D0 (en) 2023-06-22 2023-08-09 Matoke Holdings Ltd Antimicrobial device
CN117942393B (zh) * 2023-10-20 2025-09-19 成都依思康生物科技有限公司 一种疫苗佐剂、疫苗组合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5980875A (en) * 1996-04-12 1999-11-09 Mousa; Mahmoud A. Honey preparations
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
FR2769504B1 (fr) * 1997-10-13 2000-03-10 Oreal Utilisation du miel en tant qu'agent diminuant l'adhesion des micro-organismes
NL1017333C2 (nl) * 2001-02-12 2002-08-13 Gent Natural Products Van Cosmetisch resp. farmaceutisch preparaat.
AU2003234758B2 (en) * 2002-08-13 2009-04-02 Derma Sciences, Inc. Composition
BE1017155A3 (nl) * 2006-06-01 2008-03-04 Sanomedical Bvba Wondverzorgingsproduct.
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
DE102008034944B4 (de) * 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion
JP5750404B2 (ja) * 2012-06-14 2015-07-22 株式会社山田蜂蜜研究所 抗菌剤及び化粧料
BR112017016545A2 (pt) * 2015-02-03 2018-04-10 Matoke Holdings Ltd fibras e composições antimicrobianas

Also Published As

Publication number Publication date
BR112018001279A2 (pt) 2018-09-11
PH12018500374A1 (en) 2018-08-20
JP2018527320A (ja) 2018-09-20
AU2016296150A1 (en) 2018-03-01
CA2990326A1 (fr) 2017-01-26
US20180318399A1 (en) 2018-11-08
EP3324998A1 (fr) 2018-05-30
RU2018105622A3 (fr) 2020-02-21
CO2018001628A2 (es) 2018-11-22
MX2018001002A (es) 2018-09-28
GB2556567A (en) 2018-05-30
WO2017013448A1 (fr) 2017-01-26
RU2018105622A (ru) 2019-08-27
HK1256251A1 (zh) 2019-09-20
CN107847566A (zh) 2018-03-27
KR20180051501A (ko) 2018-05-16
GB201801667D0 (en) 2018-03-21

Similar Documents

Publication Publication Date Title
MA42910A (fr) Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène
MA50949B1 (fr) Anticorps anti-ctla-4 et leurs procédés d'utilisation
MX2017013535A (es) Metodos y composiciones de limpieza personal concentradas.
MX2023000289A (es) Moleculas que tienen utilidad plaguicida, e intermediarios, composiciones, y procesos, relacionados a las mismas.
MA34909B1 (fr) Triterpénoïdes modifi2s en c-17 et c-3 presentant une activité inhibitrice de la maturation du vih
TN2014000195A1 (fr) 2-thiopyrimidinones
MX2019010318A (es) Composiciones limpiadoras cosmeticas.
MX390521B (es) Composiciones con polimeros anionicos y cationicos
MA33197B1 (fr) Inhibiteurs de tripeptide époxy cétone protéases cristallines
MA33256B1 (fr) Anticorps et immunoconjugués anti-fcrh5 et procédés d'utilisation
MA39211B1 (fr) Composés tricycliques comme agents anti-cancers
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
MA33208B1 (fr) Anticorps anti-fgfr3 et procédés d'utilisation de ceux-ci
EP3695830A4 (fr) Utilisation d'une composition comprenant des exosomes dérivés de cellules souches en tant que principe actif pour le renforcement et l'amélioration fonctionnelle de la barrière cutanée
MA50406B1 (fr) Inhibiteurs pyrazole de magl
MA46548A (fr) Fsh pour le traitement de l'infertilité
ZA201908610B (en) Il-15 protein complex pharmaceutical composition and uses thereof
MX2018008845A (es) Moléculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos, relacionados con ellas.
MA33693B1 (fr) Dérivés de pyrazole qui modulent la stéroyl-coa désaturase
MA46819B1 (fr) Streptococcus thermophilus pour utilisation dans la préparation de produits fermentés
MX371306B (es) Composiciones concentradas para la limpieza personal y usos.
WO2017147557A8 (fr) Nouvelles jonctions trois voies d'arnp
MX2018002332A (es) Moleculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos, relacionados con ellas.
MA38678A1 (fr) Dérivés nucléosidiques 4'-azido, 3'désoxy-3'-fluoro substitués
PL1962815T3 (pl) Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne